Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9

被引:87
作者
Otake, Y [1 ]
Walle, T [1 ]
机构
[1] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA
关键词
D O I
10.1124/dmd.30.2.103
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There is very limited information on cytochrome P450 (P450)-mediated oxidative metabolism of dietary flavonoids in humans. In this study, we used human liver microsomes and recombinant P450 isoforms to examine the metabolism of two flavonols, galangin and kaempferide, and one flavone, chrysin. Both galangin and kaempferide, but not chrysin, were oxidized by human liver microsomes to kaempferol, with K-m values of 9.5 and 17.8 muM, respectively. These oxidations were catalyzed mainly by CYP1A2 but also by CYP2C9. Consistent with these observations, the human liver microsomal metabolism of galangin and kaempferide were inhibited by the P450 inhibitors furafylline and sulfaphenazole. In addition, CYP1A1, although less efficient, was also able to oxidize the two flavonols. Thus, dietary flavonols are likely to undergo oxidative metabolism mainly in the liver but also extrahepatically.
引用
收藏
页码:103 / 105
页数:3
相关论文
共 34 条
[1]   Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin [J].
Ashida, H ;
Fukuda, I ;
Yamashita, T ;
Kanazawa, K .
FEBS LETTERS, 2000, 476 (03) :213-217
[2]   Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially [J].
Ciolino, HP ;
Daschner, PJ ;
Yeh, GC .
BIOCHEMICAL JOURNAL, 1999, 340 :715-722
[3]   The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor [J].
Ciolino, HP ;
Yeh, GC .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1340-1346
[4]   CHARACTERIZATION OF THE INHIBITION OF P4501A2 BY FURAFYLLINE [J].
CLARKE, SE ;
AYRTON, AD ;
CHENERY, RJ .
XENOBIOTICA, 1994, 24 (06) :517-526
[5]  
Clement B, 1997, DRUG METAB DISPOS, V25, P1266
[6]   Bioflavonoids: selective substrates and inhibitors for cytochrome P450CYP1A and CYP1B1 [J].
Doostdar, H ;
Burke, MD ;
Mayer, RT .
TOXICOLOGY, 2000, 144 (1-3) :31-38
[7]   Consumption of onions and a reduced risk of stomach carcinoma [J].
Dorant, E ;
VanDenBrandt, PA ;
Goldbohm, RA ;
Sturmans, F .
GASTROENTEROLOGY, 1996, 110 (01) :12-20
[8]   Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes [J].
Eagling, VA ;
Tjia, JF ;
Back, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (02) :107-114
[9]   Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells [J].
Galijatovic, A ;
Otake, Y ;
Walle, UK ;
Walle, T .
XENOBIOTICA, 1999, 29 (12) :1241-1256
[10]   Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine [J].
Giancarlo, GM ;
Venkatakrishnan, K ;
Granda, BW ;
von Moltke, LL ;
Greenblatt, DJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (01) :31-36